DILATREND
|
Siegfried
|
carvedilol |
Antianginoso Antihipertensivo |
12.5 mg comp.ran.x 28 | $13.989,32 | (21/02/25) |
SIFAR |
Producto Reconocido |
|
PAMI |
|
AF $4.206,44 |
|
|
IOMA |
Cobertura Monto Fijo |
OS $8.844,72 AF $5.144,60 |
|
|
|
|
12.5 mg comp.ran.x 30 | $14.409,00 | (21/02/25) |
PAMI |
|
AF $4.394,12 |
|
|
IOMA |
Cobertura Monto Fijo |
OS $9.097,50 AF $5.311,50 |
|
|
|
|
12.5 mg comp.ran.x 56 | $22.851,11 | (21/02/25) |
SIFAR |
Producto Reconocido |
|
PAMI |
|
AF $5.856,64 |
|
|
IOMA |
Cobertura Monto Fijo |
OS $15.142,54 AF $7.708,57 |
|
|
|
|
25 mg comp.ran.x 28 | $17.813,41 | (21/02/25) |
SIFAR |
Producto Reconocido |
|
PAMI |
|
AF $4.951,90 |
|
|
IOMA |
Cobertura Monto Fijo |
OS $11.217,77 AF $6.595,64 |
|
|
|
|
25 mg comp.ran.x 30 | $17.813,12 | (21/02/25) |
PAMI |
|
AF $5.128,82 |
|
|
IOMA |
Cobertura Monto Fijo |
OS $11.235,45 AF $6.577,67 |
|
|
|
|
25 mg comp.ran.x 56 | $29.975,49 | (21/02/25) |
SIFAR |
Producto Reconocido |
|
PAMI |
|
AF $7.443,69 |
|
|
IOMA |
Cobertura Monto Fijo |
OS $19.121,41 AF $10.854,08 |
|
|
|
|
3.125 mg comp.ran.x 28 | $6.137,44 | (21/02/25) |
SIFAR |
Producto Reconocido |
|
PAMI |
|
AF $1.804,16 |
|
|
IOMA |
Cobertura Monto Fijo |
OS $4.203,90 AF $1.933,54 |
|
|
|
|
3.125 mg comp.ran.x 30 | $6.135,84 | (21/02/25) |
PAMI |
|
AF $1.866,27 |
|
|
IOMA |
Cobertura Monto Fijo |
OS $4.162,87 AF $1.972,97 |
|
|
|
|
50 mg comp.ran.x 28 | $23.086,82 | (21/02/25) |
SIFAR |
Producto Reconocido |
|
PAMI |
|
AF $6.470,82 |
|
|
IOMA |
Cobertura Monto Fijo |
OS $15.352,21 AF $7.734,61 |
|
|
|
|
6.25 mg comp.ran.x 28 | $11.650,41 | (21/02/25) |
SIFAR |
Producto Reconocido |
|
PAMI |
|
AF $3.283,81 |
|
|
IOMA |
Cobertura Monto Fijo |
OS $7.334,32 AF $4.316,09 |
|
|
|
|
6.25 mg comp.ran.x 30 | $11.651,58 | (21/02/25) |
PAMI |
|
AF $3.408,10 |
|
|
IOMA |
Cobertura Monto Fijo |
OS $7.226,66 AF $4.424,92 |
|
|
|
|
6.25 mg comp.ran.x 56 | $18.019,95 | (21/02/25) |
SIFAR |
Producto Reconocido |
|
PAMI |
|
AF $4.306,51 |
|
|
IOMA |
Cobertura Monto Fijo |
OS $11.193,12 AF $6.826,83 |
|
|
|
|
|